Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines

Oncology Reports

Volumn 24, Issue 3, 2010, Pages 747-757

  Roomi, M W ^a   Monterrey, J C ^a   Kalinovsky, T ^a   Rath, M ^a   Niedzwiecki, Aleksandra ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

EGCG; Green tea; MMP 2; MMP 9; Nutrient mixture

Indexed keywords

ACETYLCYSTEINE; ARGININE; ASCORBIC ACID; EPIGALLOCATECHIN GALLATE; GELATINASE; GELATINASE A; GELATINASE B; GREEN TEA EXTRACT; LYSINE; PENICILLIN G; PROLINE; SELENIUM; STREPTOMYCIN; TRACE ELEMENT;

ARTICLE; CANCER CELL CULTURE; CELL SECRETION; CULTURE MEDIUM; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FIBROSARCOMA; GLIOBLASTOMA; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NUTRIENT CONTENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEA; UTERUS CANCER; UTERUS LEIOMYOSARCOMA; ZYMOGRAPHY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASCORBIC ACID; CAMELLIA SINENSIS; CATECHIN; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LYSINE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICRONUTRIENTS; NEOPLASM INVASIVENESS; NEOPLASMS; PLANT EXTRACTS; PROLINE; PROTEASE INHIBITORS; TETRADECANOYLPHORBOL ACETATE;

EID: 77956323508     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000917     Document Type: Article

References (34)

1. Fidler IJ: Molecular biology of cancer: invasion and metastasis. In: Cancer: Principles and Practice of Oncology. 5th edition. De Vita VT, Hellman S and Rosenberg SA (eds). Lippincott-Raven, Philadelphia, PA, pp135-152, 1997.
2. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18, 2002.
3. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002. (Pubitemid 37328786)
4. Chambers AF and Matrisian LM: Changing views on the role of matrix metalloprotenases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997.
5. Kleiner DL and Stetler-Stevenson WG: Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43 (Suppl.): S42-S51, 1999.
6. Sakamoto Y, Mafune K, Mori M, Shiraishi T, Imamura H, Mori M, Takayama T and Makuuchi M: Overexpression of MMP-9 correltaes with grwoth of small hepatocellular carcinoma. Int J Oncol 17: 237-243, 2000.
7. Kashiwagi A: Matrix metalloproteases in hepatocellular carcinoma. A study in resected specimens from 25 patients. Tokyo Jikekai Med J 118: 33-48, 2001.
8. Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H and Herms J: Expression of matrix metalloproteinases and their inhibitors in medulloblastoma and their prognostic relevance. Clin Cancer Res 10: 4746-4753, 2004.
9. Loppä S, Saarto T, Vehmanen L, Blomqvist C and Elomaa I: A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma. Clin Cancer Res 10: 1057-1063, 2004. (Pubitemid 38198907)
10. Stearns M and Stearns ME: Evidence for increased activated metalloproteinase-2 (MMP-2a) expression associated with human prostate cancer progression. Oncol Res 8: 69-75, 1996. (Pubitemid 26134926)
11. Sato T, Sakai T, Noguchi Y, Takta M, Hirakawa S and Ito A: Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol 92: 47-56, 2004.
12. Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostör AG, Nie G, Lopata A and Salamonsen LA: Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 94: 1466-1475, 2002.
13. Roomi MW, Monterrey JC, Kalinovsky T, Rath M and Niedzwiecki A: In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors. Oncol Rep 23: 605-614, 2010.
14. Roomi MW, Monterrey JC, Kalinovsky T, Rath M and Niedzwiecki A: Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines. Oncol Rep 22: 1283-1291, 2009.
15. Roomi MW, Roomi N, Ivanov V, Kalinovsky T, Niedzwiecki A and Rath M: Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis. Oncol Rep 14: 807-815, 2005.
16. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A and Rath M: Inhibition of pulmonary metastasis of melanoma B16FO cells in C57BL/6 mice by a nutrient mixture consisting of ascorbic acid, lysine, proline, arginine and green tea extract. Exp Lung Res 32: 517-530, 2006. (Pubitemid 44973608)
17. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A and Rath M: In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine and green tea extract on human fibrosarcoma cells HT-1080. Med Oncol 23: 105-112, 2006.
18. Rath M and Pauling L: Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic analogs. Orthomolecular Med 7: 17-23, 1992.
19. Sun Z, Chen YH, Wang P, Zhang J, Gurewich V, Zhang P and Liu JN: The blockage of high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. Biochem Biophys Acta 1596: 182-192, 2002.
20. Valcic S, Timmermann BN, Alberts DS, Wachter GA, Krutzsch M, Wymer J and Guillen JM: Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs 7: 461-468, 1996.
21. Demeule M, Michaud-Levesque J, Annabi B, Gingras D, Boivin D, Jodoin J, Lamy S, Bertrand Y and Béliveau R: Green tea catechins as novel antitumor and antiangiogenic compounds. Curr Med Chem Anticancer Agents 2: 441-463, 2002.
22. Hara Y: Green Tea: Health Benefits and Applications. Marcel Dekker, Basel, New York, 2001.
23. Mukhtar H and Ahmed N: Tea polyphenols: prevention of cancer and optimizing health. AM J Clin Nutr 71: S1698-S1702, 2000.
24. Yang GY, Liao J, Kim K, Yurtow EJ and Yang CS: Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19: 611-616, 1998. (Pubitemid 28376804)
25. Taniguchi S, Fujiki H, Kobayashi H, Go H, Miyado K, Sadano H and Shimikawa R: Effect of (-) epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett 65: 51-54, 1992.
26. Wang X, Hao MW, Dong K, Lin F, Ren JH and Zhang HZ: Apoptotsis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression. Arch Pharm Res 32: 1263-1269, 2009.
27. Kawakami S, Kageyama Y, Fujii Y, Kihara K and Oshima H: Inhibitory effects of N-acetyl cysteine on invasion and MMP 9 production of T24 human bladder cancer cells. Anticancer Res 21: 213-219, 2001.
28. Morini M, Cai T, Aluigi MG, et al: The role of the thiol N-acetyl cysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers 14: 268-271, 1999.
29. Yoon SO, Kim MM and Chung AS: Inhibitory effects of selenite on invasion of HT 1080 tumor cells. J Biol Chem 276: 20085-20092, 2001. (Pubitemid 37411078)
30. Rayman MP: Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64: 527-542, 2005.
31. Schrauzer GN: Anticarcinogenic effects of selenium. Cell Mol Life Sci 57: 1864-1873, 2000.
32. Yeom CH, Lee G, Park JH, Yu J, Park S, Yi SY, Lee HR, Hong YS, Yang J and Lee S: High-dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via restriction of angiogenesis. J Transl Med 7: 70, 2009.
33. Maramag C, Menon M, Balaji KC, Reddy PG and Laxmanan S: Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability and DNA synthesis. Prostate 32: 188-195, 1997.
34. Cooke JP and Dzau VJ: Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48: 489-509, 1997. (Pubitemid 27101848)